Xbiotech | 10-Q: FY2025 Q3 Revenue: USD 0

Short Interest in XBiotech Inc. (NASDAQ:XBIT) Declines By 30.1%

XBiotech Inc. (NASDAQ:XBIT) experienced a 30.1% decline in short interest in September, with total short interest dropping to 119,500 shares from 170,900. This represents approximately 0.6% of the company's shares. The days-to-cover ratio is currently 2.3 days based on an average trading volume of 52,300 shares. Analysts maintain a consensus "Sell" rating on the stock, which is currently priced at $2.49, down 3.9%. Institutional investors hold 55.70% of the stock, with recent purchases from various hedge funds.

XBiotech Inc. Issues Correction Clarifying Director Craig Rademaker's Role with Canadian Private Equity Firms

XBiotech Inc. has clarified that director Craig Rademaker serves as a consultant to several Canadian private equity firms, focusing on capital markets activities. This correction follows their June 24, 2025 Form 8-K filing. The information is part of a news brief generated by Public Technologies, which emphasizes that the content is for informational purposes only and not financial or legal advice.

XBiotech Inc. Approves New Executive Employment Agreement for CEO John Simard, Setting $1.25 Million Base Salary and $4.53 Million Annual Bonus

XBiotech Inc. has approved a new executive employment agreement for CEO John Simard, effective October 1, 2025. The agreement maintains his base salary at $1.25 million and an annual bonus of $4.53 million, adjusted for inflation. It includes provisions for stock options and cash bonuses at the company's discretion. In case of retirement, disability, or termination without cause, he will receive severance equal to three years of salary and bonus. The agreement supersedes all previous arrangements.

XBiotech Inc. Files Initial Statement of Beneficial Ownership for Director David Spencer Soffer

XBiotech Inc. has filed an initial statement of beneficial ownership (Form 3) with the SEC, naming David Spencer Soffer as a Director. The filing is accessible through the SEC's EDGAR system. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.